je.st
news
Tag: announces
Pork Checkoff announces 2016 Pork Industry Scholarship recipients
2016-05-03 06:00:00| National Hog Farmer
The Pork Checkoff has awarded 22 scholarships to college students around the United States as part of its strategy to develop the pork industry’s future leaders. Successful applicants were selected from a pool of 35 applicants based on scholastic merit, leadership activities, involvement in the pork production industry and future plans for a career in pork production. read more
Tags: industry
announces
scholarship
recipients
Recursion Pharmaceuticals Announces Research Agreement With Sanofi Genzyme
2016-05-03 03:24:14| drugdiscoveryonline News Articles
Recursion Pharmaceuticals recently announced a research agreement with Sanofi Genzyme, the specialty care global business unit of Sanofi, to deploy its drug repurposing platform to identify new uses for Sanofi’s clinical stage molecules across dozens of genetic diseases
Tags: research
agreement
announces
pharmaceuticals
X-Chem Announces Achievement Of Milestone In Alexion Collaboration
2016-05-03 03:14:35| drugdiscoveryonline News Articles
X-Chem, Inc. (X-Chem), a privately held biotechnology company utilizing its industry-leading DNA-Encoded X-Chem (DEX) drug discovery platform for the identification of first-in-class small molecule therapeutics, recently announced that it has achieved a milestone in its drug discovery collaboration with Alexion Pharmaceuticals, Inc., triggering a payment to X-Chem
Tags: collaboration
achievement
announces
milestone
Partners HealthCare Announces The 2016 Disruptive Dozen' Technologies That Can Revolutionize Cancer Care
2016-05-03 03:10:11| drugdiscoveryonline News Articles
Partners HealthCare recently announced its selections for the second annual “Disruptive Dozen,” the 12 emerging technologies with the potential to revolutionize cancer care over the next decade
Tags: care
partners
technologies
cancer
Trevena Announces Successful End-Of-Phase 2 Meeting With FDA And Outlines Phase 3 Program For Oliceridine
2016-05-03 02:52:15| drugdiscoveryonline News Articles
Trevena, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of biased ligands targeting G protein coupled receptors, recently announced the successful completion of the End-of-Phase 2 Meeting process with the United States Food and Drug Administration (FDA)
Tags: for
program
meeting
successful
Sites : [489] [490] [491] [492] [493] [494] [495] [496] [497] [498] [499] [500] [501] [502] [503] [504] [505] [506] [507] [508] next »